Cargando…

Serum GGT/ALT ratio predicts vascular invasion in HBV-related HCC

BACKGROUND: The gamma-glutamyl transferase (GGT) to alanine aminotransferase (ALT) ratio has been reported as an effective predictor of the severity of hepatitis and HCC. The purpose of this study was to determine the role of the GGT/ALT ratio in the prediction of vascular invasion and survival outc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Zhifeng, Zhu, Yiming, Ni, Xiaochun, Lin, Jiayun, Li, Hongjie, Zheng, Lei, Zhang, Chihao, Qi, Xiaoliang, Huo, Haizhong, Lou, Xiaolou, Fan, Qiang, Bao, Yongyang, Luo, Meng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8479900/ https://www.ncbi.nlm.nih.gov/pubmed/34583704 http://dx.doi.org/10.1186/s12935-021-02214-1

Ejemplares similares

Prognostic Value of Serum Osteoprotegerin Level in Patients With Hepatocellular Carcinoma Following Surgical Resection
por: Zhang, Chihao, et al.
Publicado: (2021)

COX-2/sEH Dual Inhibitor PTUPB Alleviates CCl(4)-Induced Liver Fibrosis and Portal Hypertension
por: Zhao, Zhifeng, et al.
Publicado: (2021)

LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation
por: Zhang, Qi, et al.
Publicado: (2021)

Prognostic value of pretreatment serum alanine aminotransferase/aspartate aminotransferase (ALT/AST) ratio and gamma glutamyltransferase (GGT) in patients with esophageal squamous cell carcinoma
por: Huang, Hao, et al.
Publicado: (2017)

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
por: Ding, Bisha, et al.
Publicado: (2019)

The prognostic value of De Ritis (AST/ALT) ratio in patients after surgery for urothelial carcinoma: a systematic review and meta-analysis
por: Hu, Xu, et al.
Publicado: (2020)

Urinalysis and Urinary GGT-to-Urinary Creatinine Ratio in Dogs with Acute Pancreatitis
por: Gori, Eleonora, et al.
Publicado: (2019)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

UBQLN4 promotes progression of HCC via activating wnt-β-catenin pathway and is regulated by miR-370
por: Yu, Yan, et al.
Publicado: (2020)

Relationship between TRAF6 and deterioration of HCC: an immunohistochemical and in vitro study
por: Li, Jian-jun, et al.
Publicado: (2016)

MCCC2 promotes HCC development by supporting leucine oncogenic function
por: Chen, Yu-Yan, et al.
Publicado: (2021)

HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021)

Preoperative CA19-9 and GGT ratio as a prognostic indicator in ampullary carcinoma
por: Chen, Rui-Qiu, et al.
Publicado: (2023)

HBV-Induced Immune Imbalance in the Development of HCC
por: Chen, Yongyan, et al.
Publicado: (2019)

Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
por: You, Maojun, et al.
Publicado: (2023)

Identification of significant modules and hub genes involved in hepatic encephalopathy using WGCNA
por: Zhang, Chihao, et al.
Publicado: (2022)

1248. Relationship Between ALT and New HBV Biomarkers in HBV/HIV Coinfected Persons Started on Antiviral Therapy
por: Rouster, Susan D, et al.
Publicado: (2022)

FTH promotes the proliferation and renders the HCC cells specifically resist to ferroptosis by maintaining iron homeostasis
por: Hu, Wanye, et al.
Publicado: (2021)

Decreased expression of the Nkx2.8 gene correlates with tumor progression and a poor prognosis in HCC cancer
por: Qu, Lei, et al.
Publicado: (2014)

Prognostic role of PD-L1 for HCC patients after potentially curative resection: a meta-analysis
por: Liu, Gao-Min, et al.
Publicado: (2019)

Gly-tRF enhances LCSC-like properties and promotes HCC cells migration by targeting NDFIP2
por: Zhou, Yongqiang, et al.
Publicado: (2021)

Association between IL-18 polymorphisms, serum levels, and HBV-related hepatocellular carcinoma in a Chinese population: a retrospective case–control study
por: Bao, Jingui, et al.
Publicado: (2015)

Serum GP73 is complementary to AFP and GGT-II for the diagnosis of hepatocellular carcinoma
por: HOU, SI-CONG, et al.
Publicado: (2013)

Study on liver histopathology of chronic HBV infected patients with different normal ALT values
por: Zeng, Zhan, et al.
Publicado: (2022)

GGT5 Is an Independent Prognostic Biomarker in Stomach Adenocarcinoma
por: Huang, Yong, et al.
Publicado: (2022)

Molecular Signature and Immune Landscape of HCV-Associated Hepatocellular Carcinoma (HCC): Differences and Similarities with HBV-HCC
por: De Battista, Davide, et al.
Publicado: (2021)

α1-antitrypsin and its C-terminal fragment attenuate effects of degranulated neutrophil-conditioned medium on lung cancer HCC cells, in vitro
por: Zelvyte, Inga, et al.
Publicado: (2004)

Circ-ZEB1.33 promotes the proliferation of human HCC by sponging miR-200a-3p and upregulating CDK6
por: Gong, Yuhua, et al.
Publicado: (2018)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
por: Wang, Wenhui, et al.
Publicado: (2022)

The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
por: Sajid, Muhammad, et al.
Publicado: (2022)

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
por: Huang, Yan, et al.
Publicado: (2022)

Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis
por: Bao, Yuhai, et al.
Publicado: (2019)

A case of idiopathic GGT elevation with acute hepatitis A
por: Singh, Jaspreet, et al.
Publicado: (2019)

Serum GGT and serum ferritin as early markers for metabolic syndrome
por: Mohapatra, Eli, et al.
Publicado: (2020)

Immunological alterations after immunotherapy with short lived HBV‐TCR T cells associates with long‐term treatment response in HBV‐HCC
por: Tan, Anthony Tanoto, et al.
Publicado: (2021)

Clinical application value of hepatitis B virus basal core promoter 1762/1764 and GGTII and GGT in patients with HBV-DNA-positive primary liver cancer
por: Qiu, Shunhua, et al.
Publicado: (2023)

TLR3 Plays Significant Roles against HBV-Associated HCC
por: Chen, Xiao-lan, et al.
Publicado: (2015)

Viral integration drives multifocal HCC during the occult HBV infection
por: Chen, Xiao-Ping, et al.
Publicado: (2019)

Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV
por: Akkiz, H, et al.
Publicado: (2020)

Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV
por: De Matteis, Serena, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p1i5ljd5u5mbo45m5qabav2rls